Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure

スポンサーリンク

概要

• 論文の詳細を見る
• 2012-08-01

著者

• YOSHIHARA Kazutaka

  Translational Medicine & Clinical Pharmacology Department, Daiichi Sankyo Company, Ltd.

• Ieiri Ichiro

  Department Of Clinical Pharmacokinetics Graduate School Of Pharmaceutical Sciences Kyushu University

• Sugiyama Yuichi

  Department Of Applied Biological Science Faculty Of Science And Technology Science University Of Tok

• ISHIZUKA Hitoshi

  Translational Medicine and Clinical Pharmacology Department, Daiichi Sankyo

• WALKER Joseph

  Translational Medicine and Clinical Pharmacology Department, Daiichi Sankyo Pharma Development

• ENDO Seiko

  Translational Medicine and Clinical Pharmacology Department, Daiichi Sankyo

• FUKAHORI Aiko

  Discovery Science and Technology Department, Daiichi Sankyo RD Novare

• TOKUHIRO Shinya

  Translational Medicine and Clinical Pharmacology Department, Daiichi Sankyo

• SHINAGAWA Akira

  Discovery Science and Technology Department, Daiichi Sankyo RD Novare

• SUGIYAMA YUICHI

  Department of Molecular Pharmacokinetics, Graduate School of Pharmaceutical Sciences, The University of Tokyo

関連論文

• 高血圧症患者におけるオルメサルタン及びアゼルニジピンの比較薬力学 : 母集団薬物動態 / 薬力学解析
• Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome
• Polymorphism of MDR1 Gene in healthy Japanese Subjects : A Novel SNP with an Amino Acid Substitution (Glu108Lys)
• Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia
• Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866)
• QUANTITATIVE RELATIONSHIP BETWEEN IN VIVO BENZODIAZEPINE RECEPTOR OCCUPANCY AND CEREBRAL METABOLIC CHANGE IN THE MOUSE
• BINDING, INTERNALIZATION AND DEGRADATION OF ATRIAL NATRIURETIC PEPTIDE IN ISOLATED CHOROID PLEXUS
• THE TRANSPORT SYSTEM OF BENZYLPENICILLIN IN THE BLOOD-CEREBROSPINAL FLUID BARRIER
• THE EFFECT OF BASIC DRUGS ON THE HEPATIC TRANSPORT OF CARDIAC GLYCOSIDES IN RATS
• THE TRANSPORT SYSTEM OF CIMETIDINE FROM THE RAT CEREBROSPINAL FLUID : IN VIVO AND IN VITRO STUDIES
• INTERACTION OF OUABAIN AND ROSE BENGAL WITH RAT LIVER PLASMA MEMBRANES
• 22D-11-2 Modifying the pharmacokinetics of the anticancer drug CPT-11, and its active metabolite SN-38, aimed at reducing the biliary excretion of SN-38 and its gastrointestinal toxicity.
• Galactosyldiacylglycerol, a Mammalian DNA Polymerase α-Specific Inhibitor from a Sea Alga, Petalonia bingbamiae
• "S2-4 STRATEGIC PROPOSALS FOR AVOIDING TOXIC INTERACTIONS WITH DRUGS FOR CLINICAL USE DURING DEVELOPMENT AND AFTER MARKETING OF A NEW DRUG : PHARMACOKINETIC CONSIDERATION (Strategy how we can learn drug-drug interaction during the development
• POSSIBLE MECHANISMS FOR THE CHANGES IN MICROCLIMATE-pH IN THE RAT SMALL INTESTINE AND EFFECTS OF PHENOTHIAZINE DERIVATIVES IN VIVO
• Expression and Regulation of Breast Cancer Resistance Protein and Multidrug Resistance Associated Protein 2 in BALB/c Mice(Pharmacology)
• Effect of Genetic Polymorphism of OATP-C (SLCO1B1) on Lipid-Lowering Response to HMG-CoA Reductase Inhibitors
• Dubin-Johnson 症候群患者に認めたABCC2遺伝子の部分欠損(exon 7 全域)例
• FORMATION OF HIGHLY ANALGESIC MORPHINE-6-GLUCURONIDE FOLLOWING PHYSIOLOGIC CONCENTRATION OF MORPHINE IN HUMAN BRAIN
• Pharmacokinetic interaction between pravastatin and olmesartan in relation to SLCO1B1 polymorphism
• Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
• Pharmacogenetic determinants of variability in lipid-lowering response to pravastatin therapy
• Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects
• Construction of the in vitro transporter experimental systems for prediction of the dexification of drugs in human liver : Utilization of human cryopreserved hepatocytes and double transfectants
• Effects of Serum Albumin and Liver Cytosol on CYP2C9-and CYP3A4-mediated Drug Metabolism
• Lack of Contribution of P-Glycoprotein (P-gp) to Transport via the Mouse Blood-Cerebrospinal Fluid Barrier
• The Effects of Genetic Polymorphisms of CYP2C9 and CYP2C19 on Phenytoin Metabolism in Japanese Adult Patients with Epilepsy : Studies in Stereoselective Hydroxylation and Population Pharmacokinetics
• Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs
• The effect of 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) enantiomers, major metabolites of phenytoin, on the occurrence of chronic side effects : In vivo and in vitro studies
• Drug interactions of zonisamide with phenytoin and sodium valproate: serum cncentrations and protein binding
• The Effect of Phenytoin Withdrawal on Valproic Acid Free Fraction : A Case Report
• FUTURE PROSPECTS FOR TOXICOKINETICS : PREDICTION OF DRUG DISPOSITION AND ADVERSE EFFECTS IN HUMANS FROM IN VITRO MEASUREMENTS OF DRUG METABOLISM, TRANSPORT AND BINDING
• Report 3 : FUTURE PROSPECTS FOR TOXICOKINETICS : ITS ABILITY TO PREDICT DRUG ADVERSE EVENTS IN HUMANS (TOXICOKINETICS)
• Dosing Time-Dependency of the Arthritis-Inhibiting Effect of Tacrolimus in Mice
• Association study of genetic polymorphisms of drug transporters, SLCO1B1, SLCO1B3 and ABCC2, in African-Americans, Hispanics and Caucasians and olmesartan exposure
• Predictive performance of Bayesian method in a simulation work: One-compartment open linear model containing an oral route.

もっと見る 閉じる

スポンサーリンク